It has been suggested that an inhibitory ECM containing chondroitin-6-sulfate proteoglycan (C-GS-PG) and tenascin (TN), which appears homogeneously in the core of the OB following afferent fiber arrival, helps position ingrowing olfactory axons in the prospective glomerular layer (GL) (Gonzalez and Gonzalez et al., 1993) . Later, a similar ECM associated with astrocytes envelopes axonal glomeruli in rings, suggesting that axons may control the precise ECM patterning.
The question remains whether formation of the matrix ring pattern around each axonal glomerulus is an intrinsic property of the matrix-producing cells or a response to developing axons. To determine if the organization of glial associated matrix in the OB was dependent on the presence of axons, we studied the effect of unilateral injection of a neurotoxin into the olfactory epithelium of postnatal rats. Using olfactory marker protein (OMP), 8-tubulin (TUJl) antibodies, and Nissl staining, we found that at 5 and 10 d following neurotoxin administration the number of glomeruli decreased by an average of 77.0% in the injected side. At the same time, we observed that the TN/C-GS-PG rings and periglomerular cells were present only around the remaining small number of glomeruli.
Elsewhere, ECM expression and the periglomerular cell configuration were more disorganized in the GL. The pattern of glial fibrillary acidic protein (GFAP) did not change significantly.
We found that OMP staining, @-tubulin immunoreactivity, and periglomerular cells reformed in a glomerular-like pattern as the olfactory axons reformed by 20 d. As the glomeruli-shaped collection of axon terminals reappeared, TN/C-GS-PG immunoreactivity also reoccurred in rings around the new axon bundles. Again, at this later stage, the expression of GFAP was similar in both sides. In our previous study (Gonzalez et al., 1993) , we suggested that the initial gross positioning of glomeruli may be controlled by the overall positioning of TN/C-GS-PG.
In the present study, we suggest that the formation of TN/C-GS-PG in the precise ring pattern around glomeruli appears to be dependent upon the presence of bundled olfactory axons. Various mechanisms are discussed that may explain the dynamic change in ECM expression that occurs inside the glomerulus after the neurotoxin treatment.
Received Sept. 1, 1993; revised Mar. 28, 1994 , accepted Apr. 13, 1994 . We thank Catherine Doller for her excellent assistance. This work was supported by NIH Grant NS-257 13 and a minority supplementary grant. The olfactory bulb (OB) is the first CNS synaptic relay for peripheral olfactory axons within the CNS (Golgi, 1875; Ramon y Cajal, 1911; Allison, 195 1; Valverde, 1965; Gesteland et al., 1982) . This region is of great importance, not only for its role as a sensory integration center, but also as a model system for regeneration studies. It is the only place in the mammalian CNS that exhibits significant regrowth of its peripherally innervating axons with substantial restoration of function (Monti- Graziadei and Graziadei, 1979; Graziadei and Monti-Graziadei, 1980; Brunjes and Frazier, 1986) .
The OB is characterized by the curious bundling pattern of its afferent axons into glomeruli that do not grow deeply into the brain. Previous studies by us (Gonzalez et al., 1993) and others (Tolbert and Oland, 1990; Gascuel and Mason, 199 1; Bailey and Shipley, 1993; Goodman et al., 1993) have suggested that the interaction between olfactory axons and bulb glia may help form the axonal glomerular pattern. Gonzalez et al. (1993) suggested that astroglial-associated ECM molecules, tenascin (TN), and chondroitin-6-sulfate-containing proteoglycan (C-6S-PG), which are present in the core ofthe early developing OB prior to glomeruli development, form a molecular "wall" that helps confine olfactory axons within the olfactory nerve layer (ONL) at the outer edge of the astroglial territory. Once glomeruli form, the "wall" expands peripherally to surround each glomerulus.
A similar compartmental pattern of glycoconjugate rings has been described in the somatosensory cortex (Cooper and Steindler, 1986a; Steindler et al., 1990) . Here, ECM rings are associated with intensely glial fibrillary acidic protein (GFAP)-positive astrocytes (Cooper and Steindler, 1986b; Steindler et al., 1990) around somatosensory cortical "barrels" that are related to individual facial vibrissae. In this region, three boundary molecules have been found, the glycoprotein TN (Crossin et al., 1989; Steindler et al., 1989 Steindler et al., , 1990 and two types of proteoglycans. The first is cytotactin binding proteoglycan (CTB-PG) (Hoffman et al., 1988; Crossin et al., 1989 ) and the second is a proteoglycan named neurocan bearing the epitope lG2 (Oohira et al., 1994) . It has been suggested that neurocan is synthesized largely by neurons . During the critical period, which in the somatosensory cortex appears to end sometime between postnatal days 1 and 5, lesions of the vibrissae-follicles affect maintenance of the barrels (Van der Loos and Woolsey, 1973; Weller and Johnson, 1975) What dictates the formation of compartmentalized neuronal patterns in regions in which both neurons and glia could potentially participate?
Some suggest that glia play a vital role Shipley, 1992, 1993; , while others maintain that axons are the players of primary importance ( Van der Loos and Woolsey, 1973; Woolsey and Wann, 1976; Graziadei and Monti-Graziadei, 1980; Crossin et al., 1989; Erzurumlu and Jhaveri, 1992) . Evidence supporting the concept that glia are important in synaptic patterning comes from Tolbert and Oland (1990) who studied the development of insect olfactory glomeruli. This study has shown that glial elements define edges for the ingrowing dendrites of second-order olfactory neurons and primary olfactory axons. Exposure to r-irradiation or injection of hydroxyurea, which reduced the number of glial cells in the moth olfactory lobe, disrupted the "condensation" of neuropil into glomeruli (Tolbert and Oland, 1990) . The idea that axons were clearly significant was reinforced by studies of the developing barrel boundaries, where the precocious arrival of axons from the thalamus prior to barrel boundary formation was carefully documented (Erzurumlu and Jhaveri, 1992) . In addition, primary visual cortex was transplanted into the primary somatosensory cortex (Schlaggar and O'Leary, 1991) , where it was found that the characteristic barrel-like matrix pattern could develop in the transplanted tissue. Furthermore, it has been demonstrated that the expression of certain proteoglycans, such as Cat-30 1, is dependent upon neuronal activity. Studies on the effects of early visual deprivation suggest that neuronal activity during the critical period of the developing central visual pathways upregulates the expression of the Cat-301 proteoglycan (Zaremba et al., 1989) . Other studies demonstrated that Cat-301 expression on the surface of hamster motor neurons requires input by large-diameter primary afferents (Kalb and Hockfield, 1990a) . During this early postnatal period its expression on motor neurons could be inhibited by blockade of the NMDA receptor at the spinal segmental level (Kalb and Hockfield, 1990b) . If glia play a role in this process, it remains unclear what forms of normal neuronal activity glial cells can react to and how glial pattern information is conveyed to their neuronal counterparts.
There is good experimental evidence that when used as substrates in vitro several glial-associated ECM molecules, TN (Faissner and Kruse, 1990; Lochter et al., 199 1; Perez and Halfter, 1993; Taylor et al., 1993) , certain keratan sulfate (KS)-containing proteoglycans (Snow et al., 1990; Cole and McCabe, 199 1; Brittis et al., 1992; Geisert and Bidanset, 1993) and certain CS-bearing proteoglycans (Snow et al., 1990; Oohira et al., 1991 Oohira et al., , 1994 Ethell, 1993; Grumet et al., 1993) , are capable of inhibiting neurite outgrowth. Indeed, their presence in the bulb (Gonzalez et al., 1993) and throughout the entire neocortex (Oohira et al., 1994) in a layered pattern prior to axon invasion could be an important factor in positioning the site of glomeruli or barrel formation, a response property that may be unique to only certain subtypes of axons. The in vitro studies have been correlated with developmental (Cooper and Steindler, 1986a; Crossin et al., 1989; Steindler et al., 1990; Bailey and Shipley, 1993; Gonzalez et al., 1993; Silver et al., 1993) and regeneration studies of other regions (Goldberger, 1974; Kliot et al., 1990 ; present study) and suggest that glial matrix glycoconjugates (like TN, CS-PG), when in high amounts relative to growth-promoting molecules, can form barriers to developing and regenerating axons in order to constrain or maintain compartmental patterns throughout the CNS. The purpose of the present study was to investigate the role of axons in the maintenance or plasticity of glial and glycoconjugate rings associated with glomeruli by describing potential glial and ECM changes in the immature postnatal rat OB after unilaterally injecting a neurotoxin (zinc sulfate) into the olfactory epithelium and allowing for regeneration of olfactory axons to occur centrally. Our previous study (Gonzalez et al., 1993) suggests that the gross positioning of glomeruli is controlled by the overall positioning of TN/C-6S-PG; however, the present data suggest that formation of TN/C-6S-PG in the precise ring pattern is dependent upon the presence of olfactory axons.
Materials and Methods
Animals. Twenty postnatal day 5 (PDS) Sprague-Dawley rats (Zivic Miller) were ice anesthetized and 20 ~1 of a neurotoxin ( 10% zinc sulfate in distilled water; Sigma Chemicals) was injected into the nasal cavity after making a small incision in the left nasal bone. A small piece of cotton was used to cover the incision and keep the solution in place. After 5,10, or 20 d the rats were anesthetized by Metofane (2,2-dichloro-1,l -difluoroethyl methyl ether) inhalation and killed by transcardiac perfusion using 4% paraformaldehyde in phosphate buffer. The tissue was postfixed overnight in the same solution, passed through a sucrose gradient (lo%, 20%, and 30%) and cryostat sectioned. The olfactory epithelium of the right side was not disturbed and was used as the control. Immature postnatal rats were chosen, because at this stage glomeruli are well shaped and distinct, although immature. We believe that glial cells and axonal arbors might be most susceptible to experimental perturbations at this time.
Immunocytochemistry. Ten micrometer adjacent sections were reacted overnight with one of the following antibodies: olfactory marker protein (OMP) (courtesy of Dr. Frank Margolis, Roche Institute of Observe the characteristic glomeruli in the CL. B, OMP-like immunoreactivity in the experimental side shows a significant decrease in the number of glomeruli in this region, while OMP-positive axons are still present in the ONL. Note a remaining glomerulus (arrow). C', TUJl staining in the control side shows glomeruli in the GL. Observe that P-tubulin-like immunoreactivity is stronger in the ONL and below the MCL. D, TUJl staining in the experimental side shows no glomeruli in the GL, while @-tubulin-like immunoreactivity is still strong in the ONL. ONL, olfactory nerve layer; GL, glomerular layer; EPL, external plexiform layer; MCL, mitral cell layer. Magnification, 400 x . Molecular Biology; diluted 1:200 in BSA/PBS), which reacts with olfactory axons; TUJ 1 (courtesy of Dr. Anthony Frankfurter, diluted 1:3000 in dilution buffer), a monoclonal antibody that is specific for a neuronspecific type III @-tubulin isoform (Lee et al., 1990) ; CS-56 [Sigma Chemical Company; diluted 1:200 in 5% NGS (normal goat serum)/ PBS], which is specific for the GAG portion of native chondroitin sulfate proteoglycan and binds to the 6-sulfated moiety; tenascin (TN), also known as cytotactin (courtesy of Dr. K. Crossin, Rockefeller University; diluted 1:300 in 5% NGSPBS); anti-glial fibrillary acidic protein (anti-GFAP: Accurate Chemical: diluted 1:500 in dilution buffer).
After incubation with the primary antibody, the tissue was washed with the appropriate buffer a1.d incubated with the specific biotinylated secondary antibody (1:200, 1 hr): RAG IgG (Vector Labs) for OMP, GAM IgG (Chemicon International, Inc.) for TUJl, GAM IgM (Chemicon International Inc.) for CS-56, and GAR IgG (Sigma Immuno Chemicals) for TN and GFAP. Following removal of the secondary antibody, the tissue was washed and incubated 30 min in strepavidin conjugated to Texas red (1: 100; Amersham). The sections were rinsed and coverslipped in Citifluor (Citifluor Ltd.) and viewed on a Leitz Orthoplan 2 fluorescent microscope.
Glomeruli quantitation. In order to describe any changes in the number of glomeruli 5, 10, and 20 d after the zinc sulfate injection, control and experimental OMP-immunoreactive glomeruli at the rostra1 end of the bulb were counted over a distance of 750 pm of coronal tissue sections. Five sections, 10 pm each, were counted around their entire perimeter. Each section was separated from the next by about 150 pm. The average size of a glomerulus ranged from 50 to 100 brn; thus, the numbers counted represent different glomeruli and not the repeated counting of the same glomerulus in the different sections. OMP staining was chosen to identify the axonal aspect of the glomeruli. It describes clearly the shape of olfactory axon terminals that take the shape of glomeruli. We have focused our attention largely on the olfactory axons and associated astrocytes. It is important to stress, however, that other components of the glomeruli (like periglomerular cells and mitral cell glomeruli in the GL of the control side. B, CS-56 staining in the experimental side shows no glomeruli in the GL and a similar nattern of holes. as seen with TUJ 1. C, TN staining in the control side shows a few "rings" (arrows) in the GL. D, TN staining in the experimental side lacks glomdruli. E, GFAP staining in the cot&o1 side shows the pattern of astro&tes in the.OB. Note that GFAP-like immunoreactivity is stronger in the GL. F, GFAP staining in the experimental side shows a similar pattern of astrocytes as in the control (E). ONL, olfactory nerve layer; GL, glomerular layer; EPL, external plexiform layer; MCL, mitral cell layer. Magnification, 400 x . dendrites) may also be affected by deafferentation. For this reason, Nissl staining was done.
Nissl staining.
Adjacent coronal sections of the OB were stained with cresyl violet (0.4 gm in 100 ml of distilled water; Aldrich) for 5 min. Sections were then rinsed in 50%, 70%, 80%, 90%, and 100% ethyl alcohol, 5 min each. Afterward, the sections were dipped briefly in xylene and mounted in Permount.
Results

Five or ten days after zinc sulfate injection
The neurotoxin injection did not kill all olfactory neurons or their axons. The overall result was a 7 1.7% (after 5 d) or 82.3% (after 10 d) decrease in the number of glomeruli in the injected side (left) as compared to the control side (right). These results are summarized in Figure 1 .
Olfactory marker protein (OMP) antibodies were used in this study to describe the pattern of olfactory axons in the olfactory bulb (OB), while TUJl antibodies were used to describe the overall pattern of axons in the same tissue. The normal pattern of glomeruli in the OB is shown with OMP-like immunoreactivity in the control side ( Fig. 2A) . Five days after zinc sulfate injection into the left olfactory epithelium, there was a 7 1.7% decrease in the number of glomeruli in the glomerular layer (GL) of the OB (Figs. 1, 2B ). The overall normal pattern of axons in the OB, including olfactory and mitral cell axons, is shown with fi-tubulin immunoreactivity (TUJ 1) (Fig. 2C) . TUJ 1 was used mainly to eliminate the possibility that the decrease in the number of glomeruli was due to downregulation of OMP staining rather than axon elimination. Indeed, p-tubulin immunoreactivity in neurotoxin-lesioned animals also showed no glomerular pattern in the GL, suggesting that the decrease in number of glomeruli in the injected side (Fig. 20) occurred because of a loss of olfactory axons that normally bundle. Some surviving olfactory axons not in a glomerular configuration persisted in the glomerular region.
Chondroitin-6-sulfate-containing proteoglycan (C-6S-PG) and tenascin (TN) were found associated with glial fibrillary acidic protein (GFAP)-positive astrocytes in the developing OB (Gonzalez et al., 1993) . The normal pattern of C-6S-PG and TN in the shape of rings is shown in the control OB (Fig. 3A ,C, respectively) at PDlO. Five days after the neurotoxin injection on PD5 in the left olfactory epithelium, the ring pattern was disturbed (Fig. 3&D) . Noteworthy was the fact that the GL on the experimental side (Fig. 3&D ) was considerably narrower than the control (Fig. 3A,C) . However, GFAP staining was similar in both cases (Fig. 3E,F) . It is not clear why shrinkage of the GL occurred, but it seems to be a reasonable consequence of the decrease in the number of olfactory axons. We observed that the TN/C-6S-PG glomeruli rings were only present around the remaining small number of well-shaped glomemli in the OB (observed by double labeling with OMP and TN and CS-56 antibodies, respectively; data not shown). Elsewhere, the expression of TN/C-6S-PG was more homogeneous and disorganized in the GL (Fig. 3&D) . Importantly, the expression of GFAP did not change significantly in the experimental side (Fig.  3F ) as compared to the control side (Fig. 3E) .
Ten days after the neurotoxin injection in the left olfactory nasal epithelium, the decrease in the number of glomeruli was 82.3% (Fig. 1) in the corresponding OB. A similarly disrupted pattern of glomeruli and matrix rings was also found in the GL (Fig. 4) . Not all olfactory axons were killed by the neurotoxin injection, but, rather, the number that were killed was sufficient enough to affect axon glomerular organization. In addition, the pattern of cells that normally surround the axonal glomeruli was also disturbed (see Fig. 7A,B) .
Twenty days after zinc sulfate injection At this stage, many olfactory axons had recovered from the lesion and reorganization of their axons and/or regeneration from the nasal epithelium was evident as new glomemli appeared in the GL. Figure 1 summarizes these results. The 29% decrease in the number of glomeruli is much less than that observed after 5 d (7 1.7%) or 10 d (82.3%) after the injection. Thus, glomeruli reformed between 10 and 20 d postlesion.
Using OMP antibodies, a high number of glomeruli were found in both control (Fig. 5A ) and 20 d experimental (Fig. 5B) OBs. Normal, well-shaped glomeruli were present in the experimental OB (Fig. 5B) . New glomeruli were also evident with TUJl antibodies (Fig. 5D) . As glomeruli reappeared, TN/C-6S-PG immunoreactivity was reexpressed in rings around the new glomeruli (Fig. 6A-D) . Again, at this later stage, the expression of GFAP was similar in both control (Fig. 6E) and experimental (Fig. 6F) sides. Note that at this stage there is a higher density of GFAP-positive astrocytes inside rather than around the glomeruli. We also observed that in the GL the ring-like periglomerular cell pattern that had become disturbed at 5 and 10 d after the neurotoxin injection was now restored around each glomerulus (Fig. 7C,D) .
Discussion
We have used a variety of immunohistochemical markers to study glial and ECM changes in the olfactory bulb (OB), after the administration of a neurotoxin (zinc sulfate) in the olfactory epithelium. Our study suggests that an interaction between regenerating olfactory axons and cells that have associated glycoconjugate matrix, is necessary in order to control the formation of TNKS-PG in the precise ring pattern around individual glomeruli. Although we are not certain that this particular bulb ECM is produced by glia, it is clearly associated with them. Evidence confirming TN/C-6S-PG ECM production by glia comes from in vitro studies (Goodman et al., 1993; Canning et al., 1994) and in situ hybridization studies (Laywell et al., 1992) where it was shown that OB and cerebellar astrocytes do make these ECM components. Although it is possible that there is a contribution from neurons, as shown by in situ hybridization studies we did not see any staining in neuronal cell bodies. Our results also suggest that the change in patterning of matrix in the vicinity of the glomeruli border and core is not simply dependent on the physical rearrangement of glia, but rather on the physical presence of olfactory axons.
It is important to stress that glia in the GL (Bailey and Shipley, 1993) as well as matrix layering in the early bulb (Gonzalez et al., 1993) are organized. Bailey and Shipley (1993) have shown that very early on, glial cells in the presumptive GL form into a "tuft," which corresponds to the region where axons coalesce to form the glomerulus. They suggested that a subpopulation of glia that are axon growth permissive could help direct glomeruli formation by forming a prepattemed template or by responding quickly to a signal from the axons. We have shown that after killing olfactory neurons and lesioning olfactory axons, which are the main effects of the neurotoxin injection, both axonal glomeruli and glycoconjugate "rings" disappeared in the GL. However, the astrocyte processes themselves, albeit GFAP pos- may mean that astrocytes "sense" alterations in the damaged olfactory axons, perhaps responding to activity changes (Zaremba et al., 1989 ) reactive microglial cells, or altered trophism, and as a result alter their glycoconjugate matrix pattern. The lack of astroglial hypertrophy was somewhat unexpected, since GFAP expression and astroglial size usually increase after a trauma or lesion. One explanation may be that since the experimental animals were immature, the gross astrocyte response was relatively diminished, an observation that has been made repeatedly in deafferented young animals (Carlstedt, 1987; Pindzola et al., 1993) .
Regeneration in the OB and other systems
It has been suggested that in the CNS, regenerative failure may be due to mechanical factors (Reier and Houle, 1988; Fawcett et al., 1989) or to macroglial-derived molecular inhibitors (Schwab, 1990; Snow et al., 1990; McKeon et al., 199 1; Petroski et al., 1991; Bovolenta et al., 1993; Fok-Seang et al., 1993; Geisert and Bidanset, 1993; Pindzola et al., 1993) much like those present in the bulb during normal development (Gonzalez et al., 1993) . Unlike other primary sensory axons innervating the CNS, the olfactory axons are unique in that they can be replaced centrally following an injury. Previous studies have described the ability of new olfactory neurons to replace degenerating olfactory axons in the CNS after sectioning the nerve (Monti- Graziadei and Graziadei, 1979; Graziadei and MontiGraziadei, 1980; Doucette et al., 1983) , partially removing the OB (Monti- Graziadei and Graziadei, 1992) or completely removing the OB (Graziadei et al., 1978) . This regenerative ability may be reinforced by the ensheathing cells (Bamett et al., 1993) Schwann-like cells that wrap olfactory axons and are present in the ONL and GL of t (arrows) . Compare the expression of C-6S-PG and TN, in the shape of rings, in control and experimental OB. E, GFAP staining in the control side shows astrocytes from the center of the OB to peripheral layers. F, GFAP staining in the experimental side shows a similar pattern as in the control (E). Asterisks demark one glomendus encapsulated and infiltrated with GFAP-positive astrocytes in E and F. ONL, olfactory herve layer; GL, glomemlar layer; EPL, external plexiform layer; MCL, mitral cell layer. Magnification: A, D, E, and F, 400 x ; B,, 250 x ; B2 and C, 500 x . and Silver * ECM Changes i n OB the OB. Perhaps, the growth-promoting cell adhesion and trophic molecules produced by these cells following injury (Raisman, 1985; Doucette, 1990; Goodman et al., 1993) and the intimate relationship between these cells and the olfactory axons along the entire pathway from the mucosa to the center of the glomerular ring, may support regeneration of olfactory axons. Another factor leading to regeneration may be the ability of certain subpopulations of the bulb astroglia to respond in a growth-promoting manner upon arrival of the peripheral axons. What is the underlying cellular mechanism by which the geometry of ECM expression changes in the GL after neurotoxin treatment? There are several possible explanations. First, there could be physical rearrangement of processes, or whole cells, that are secreting these ECMs. Although we did not see any obvious movements of GFAP-immunoreactive cells, immunolabeling of static sections with GFAP antibodies is not sufficient to eliminate this possibility. In fact, Nissl staining did reveal a change in the pattern of periglomerular cells. Second, there could be heterogeneous populations of astrocytes in the bulb, one type in the core and another in the surround of the glomerulus, that respond differently to the presence of axons. Indeed, Bailey and Shipley (1992) and Goodman et al. (1993) have shown that the bulb is composed of heterogeneous populations of glia, and that these various populations can make differential amounts of axon growth inhibitors such as CS-PG and TN (Gonzalez et al., 1993; Goodman et al., 1993) . It is possible that astroglia with axon growth-promoting properties when in association with certain axons, are those that infiltrate glomeruli cores while nonpermissive, relatively nonmalleable astroglia encapsulate them. As developing or regenerating olfactory axons approach the GL, the core population of glial cells might rearrange their matrix pattern to permit the regenerating axons to grow into the GL, but the outer population in the ring blocks growth from going further. Downregulation of axon growth-inhibiting glycoconjugate matrix may be one of several important keys to regeneration in the OB (as well as normal glomerular development), making this region at the edge of the adult CNS unlike others (e.g., DREZ of spinal cord), where reactive astroglial inhibitory matrices persist and may block centrally regenerating sensory axons indefinitively (Pindzola et al., 1993) . If we can uncover the mechanisms that underlie plasticity of ECM patterning in the bulb, then we may begin to understand how to reduce inhibitory matrices in other regions of the CNS, where regeneration fails.
